Intraday Trading Highlights
On a day when the Sensex opened lower at 81,947.31 and traded down by 0.68% at 82,007.12, Strides Pharma Science Ltd (stock ID 688428) bucked the trend with a notable rally. The stock recorded an intraday high of Rs 888.8, marking a 9.87% increase from its previous close, while its intraday low stood at Rs 792.6, reflecting a 2.02% dip. This wide price range contributed to a high intraday volatility of 8.15%, calculated from the weighted average price, underscoring active trading interest and price fluctuations throughout the session.
Strides Pharma’s day change of 10.42% outpaced the Pharmaceuticals & Biotechnology sector by 8.7%, highlighting its relative strength within the industry. The stock has now recorded gains for three consecutive trading days, accumulating an 11.33% return over this period, signalling sustained positive momentum in the short term.
Moving Average Analysis
From a technical perspective, the stock’s current price is positioned above its 5-day and 200-day moving averages, indicating short-term and long-term support levels. However, it remains below the 20-day, 50-day, and 100-day moving averages, suggesting some resistance in the medium term. This mixed moving average alignment reflects a nuanced technical setup, with recent strength tempered by longer-term trend considerations.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Comparative Performance Versus Sensex
Strides Pharma Science Ltd’s one-day gain of 11.08% starkly contrasts with the Sensex’s decline of 0.70% on the same day, underscoring the stock’s outperformance amid broader market weakness. Over the past week, the stock has advanced 12.86%, compared to a modest 0.56% rise in the Sensex. The one-month performance shows a slight decline of 1.23% for Strides Pharma, yet this remains better than the Sensex’s 3.17% fall. Over three months, the stock gained 5.72%, while the Sensex dropped 2.86%, further highlighting relative resilience.
Longer-term returns remain impressive, with a one-year gain of 37.55% against the Sensex’s 6.82%, and a three-year surge of 526.46% compared to the Sensex’s 37.80%. The five-year and ten-year performances stand at 129.77% and 60.30% respectively, though the ten-year return trails the Sensex’s 229.67% growth. Year-to-date, the stock is marginally down by 0.42%, outperforming the Sensex’s 3.79% decline.
Mojo Score and Grade Update
Strides Pharma Science Ltd currently holds a Mojo Score of 37.0, with a Mojo Grade of Sell, reflecting a downgrade from its previous Hold rating as of 19 Jan 2026. The Market Cap Grade is rated 3, indicating a mid-tier market capitalisation standing within its sector. These metrics provide a quantitative assessment of the stock’s quality and market perception as of the latest evaluation date.
Is Strides Pharma Science Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Sector and Market Context
The Pharmaceuticals & Biotechnology sector, to which Strides Pharma belongs, has experienced mixed performance in recent sessions. Despite the Sensex’s subdued trading and a decline of 0.75% at opening, Strides Pharma’s strong intraday surge highlights its distinct trading dynamics. The Sensex’s 50-day moving average remains above its 200-day moving average, signalling a longer-term bullish trend for the broader market, even as the index trades below the 50-day average on this particular day.
Strides Pharma’s ability to outperform both its sector and the broader market during a downtrend session reflects notable trading interest and price momentum. The stock’s volatility and price swings today suggest active participation from market participants, contributing to its elevated trading range and volume.
Summary of Key Intraday Metrics
To summarise, Strides Pharma Science Ltd’s intraday high of Rs 888.8 represents a 9.87% increase, with a day change of 10.42%. The stock’s volatility at 8.15% is significant relative to typical trading ranges, and its three-day consecutive gains total 11.33%. These figures collectively illustrate a strong intraday performance amid a challenging market backdrop.
Investors and market watchers will note the stock’s positioning relative to moving averages and its recent Mojo Grade downgrade, which provide additional context to its trading behaviour and market standing.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
